The long-term trend of the EPS is an important number as it indicates the present value of OptimizeRx Corporation. The EPS growth rate, as it is usually called, is typically displayed as a percentage, which is 50.00%. EPS growth is a vital measure of execution of the strategy for OptimizeRx Corporation since it indicates how well the business is allocating resources to benefit shareholders.

OptimizeRx Corporation trades as part of the application software industry and trades as part of the technology sector. The company CEO is William J. Febbo. OptimizeRx Corp is a technology solutions company serving the healthcare industry. It is engaged in providing consumer and physician platforms. Its core product offering is OPTIMIZERx and SampleMD software application.

Previous Intraday Performance:

The OPRX shares had a previous change of -0.82% which opened at 13.40 and closed at 13.29. It moved to an intraday high of 13.90 and a low of 13.27.

SeekingAlpha:  STM, OLED & EMAN among notable tech movers

Historical Performance:

Over the last five trading days, OPRX shares returned -1.63% and in the past 30 trading days it returned -8.97%. Over three months, it changed -22.37%. In one year it has changed 61.09% and within that year its 52-week high was 18.39 and its 52-week low was 7.00. OPRX stock is 89.86% above its 52 Week Low.

Our calculations result in a 200 day moving average of 12.76 and a 50 day moving average of 14.19. Right now, OPRX stock is trading 4.14% above its 200 day moving average and may be a good opportunity to buy.

SeekingAlpha:  STM, OLED & EMAN among notable tech movers


The company has a market cap of $159.7m with 12.0m shares outstanding and a float of 11.9m shares. Trading volume was 14,860 shares and has experienced an average volume of 90,102 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for OptimizeRx Corporation was -0.21 which ended on 31st of December 2017. Based on 3 analyst estimates, the consensus EPS for the next quarter is 0.00.

Below was the last reported quarterly earnings per share:
09-30-2018:  0.02
06-30-2018:  0.02

Indicators Also to Watch:

Based on the latest filings, there is 1.10% of insider ownership and 22.70% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.

I calculated the beta to be 3.34

SeekingAlpha:  RCII and ITCI among premarket losers

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is 0.85%, return on assets is 0.67%, profit margin is 2.30%, price-to-sales is 11.01 and price-to-book is 9.44.

Company Score Card:

Results are out of six:
 5  : Growth Expectations Result
 6  : Financial Safety Result
 0  : Past Performance Result
 0  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here